Interferon gamma mRNA quantitative real-time polymerase chain reaction for the diagnosis of latent tuberculosis: A novel interferon gamma release assay

Diagnostic Microbiology and Infectious Disease

Volumn 75, Issue 1, 2013, Pages 68-72

  Kim, Sunghyun ^a   Kim, Young Keun ^a   Lee, Hyejon ^b   Cho, Jang Eun ^b,c   Kim, Hyo Youl ^a   Uh, Young ^a   Kim, Young Mi ^b   Kim, Hyunjung ^b   Cho, Sang Nae ^b   Jeon, Bo Young ^a   Lee, Hyeyoung ^a  

^a Yonsei University Wonju   (South Korea)

^b Yonsei University   (South Korea)

^c Daegu Health College   (South Korea)

Author keywords

IFN ELISA; IFN mRNA Real time PCR; QFT IT; Tuberculosis

Indexed keywords

BACTERIAL ANTIGEN; GAMMA INTERFERON; MESSENGER RNA; MITOGENIC AGENT;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CELL COUNT; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; LATENT TUBERCULOSIS; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CLINICAL LABORATORY TECHNIQUES; FEMALE; HUMANS; INTERFERON-GAMMA; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TIME FACTORS; YOUNG ADULT;

EID: 84870762438     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.09.015     Document Type: Article

References (18)

1. Bibova I., Linhartova I., Stanek O., Rusnakova V., Kubista M., Suchanek M., et al. Detection of immune cell response to M. tuberculosis-specific antigens by quantitative polymerase chain reaction. Diagn Microbiol Infect Dis 2012, 72:68-78.
2. Chee C.B., Gan S.H., Khinmar K.W., Barkham T.M., Koh C.K., Liang S., et al. Comparison of sensitivities of two commercial gamma interferon release assays for pulmonary tuberculosis. J Clin Microbiol 2008, 46:1935-1940.
3. Detjen A.K., Keil T., Roll S., Hauer B., Mauch H., Wahn U., et al. Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis 2007, 45:322-328.
4. Harada N., Higuchi K., Yoshiyama T., Kawabe Y., Fujita A., Sasaki Y., et al. Comparison of the sensitivity and specificity of two whole blood interferon-gamma assays for M. tuberculosis infection. J Infect 2008, 56:348-353.
5. Kubista M., Andrade J.M., Bengtsson M., Forootan A., Jonak J., Lind K., et al. The real-time polymerase chain reaction. Mol Aspects Med 2006, 27:95-125.
6. Kumar A., Kumar A.M., Gupta D., Kanchar A., Mohammed S., Srinath S., et al. Global guidelines for treatment of tuberculosis among persons living with HIV: unresolved issues. Int J Tuberc Lung Dis 2012, 16:573-578.
7. Kvach E.J., Ferguson D., Riska P.F., Landry M.L. Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection. J Clin Microbiol 2010, 48:109-114.
8. Lee J.Y., Choi H.J., Park I.N., Hong S.B., Oh Y.M., Lim C.M., et al. Comparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir 2006, J28:24-30.
9. Lienhardt C., Glaziou P., Uplekar M., Lonnroth K., Getahun H., Raviglione M. Global tuberculosis control: lessons learnt and future prospects. Nat Rev Microbiol 2012, 10:407-416.
10. Mannhalter C., Koizar D., Mitterbauer G. Evaluation of RNA isolation methods and reference genes for RT-PCR analyses of rare target RNA. Clin Chem Lab Med 2000, 38:171-177.
11. Mazurek G.H., Jereb J., Vernon A., LoBue P., Goldberg S., Castro K. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep 2010, 59:1-25.
12. Mori T., Sakatani M., Yamagishi F., Takashima T., Kawabe Y., Nagao K., et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004, 170:59-64.
13. Palomino J.C. Current developments and future perspectives for TB diagnostics. Future Microbiol 2012, 7:59-71.
14. Pouchot J., Grasland A., Collet C., Coste J., Esdaile J.M., Vinceneux P. Reliability of tuberculin skin test measurement. Ann Intern Med 1997, 126:210-214.
15. Shah M., Dipietro D., Greenbaum A., Ketemepi S., Martins-Evora M., Marsiglia V., et al. Programmatic impact of QuantiFERON-TB gold in-tube implementation on latent tuberculosis diagnosis and treatment in a public health clinic. PLoS One 2012, 7:e36551.
16. Kabeer B.S.A., Raman B., Thomas A., Perumal V., Raja A. Role of QuantiFERON-TB gold, interferon gamma inducible protein-10 and tuberculin skin test in active tuberculosis diagnosis. PLoS One 2010, 5:e9051.
17. Turtle L., Kemp T., Davies G.R., Squire S.B., Beeching N.J., Beadsworth M.B. In routine UK hospital practice T-SPOT.TB is useful in some patients with a modest pre-test probability of active tuberculosis. Eur J Intern Med 2012, 23:363-367.
18. Uyttendaele M., Vanwildemeersch K., Debevere J. Evaluation of real-time PCR vs automated ELISA and a conventional culture method using a semi-solid medium for detection of Salmonella. Lett Appl Microbiol 2003, 37:386-391.